Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014		Jun. 30, 2015	Jun. 30, 2014
Net Sales	$ 12,910	$ 14,917		$ 25,280	$ 29,378
Cost of sales	10,146	12,344		19,681	24,077
Research and development expenses	429	419		812	810
Selling, general and administrative expenses	773	751		1,525	1,530
Amortization of intangibles	109	108		211	222
Restructuring charges	375	0		375	0
Equity in earnings of nonconsolidated affiliates	272	227		440	478
Sundry income (expense) - net	385	25		1,048	54
Interest income	11	9		28	22
Interest expense and amortization of debt discount	232	242		473	488
Income Before Income Taxes	1,514	1,314		3,719	2,805
Provision for income taxes	317	344		1,003	769
Net Income	1,197	970		2,716	2,036
Net income (loss) attributable to noncontrolling interests	(23)	3		18	20
Net Income Attributable to The Dow Chemical Company	1,220	967		2,698	2,016
Preferred stock dividends	85	85	[1]	170	170	[1]
Net Income Available for The Dow Chemical Company Common Stockholders	$ 1,135	$ 882		$ 2,528	$ 1,846
Per Common Share Data:
Earnings per common share - basic	$ 0.99	$ 0.74		$ 2.21	$ 1.54
Earnings per common share - diluted	0.97	0.73		2.15	1.52
Dividends declared per share of common stock	$ 0.42	$ 0.37		$ 0.84	$ 0.74
Weighted-average common shares outstanding - basic	1,138.1	1,178.9		1,136.9	1,184.7
Weighted-average common shares outstanding - diluted	1,249.4	1,195.2		1,248.0	1,201.5
Depreciation	$ 483	$ 525		$ 969	$ 1,042
Capital Expenditures	$ 998	$ 864		$ 1,901	$ 1,536

[1] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the three- and six-month periods ended June 30, 2014, because the effect of adding them back would have been antidilutive.